UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (date of earliest event reported): August 19, 2005
Commission File No. 0-11178
UTAH MEDICAL PRODUCTS, INC.
(Exact name of Registrant as specified in its charter)
UTAH | 87-0342734 |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
7043 South 300 West
Midvale, Utah 84047
Address of principal executive offices
Registrant's telephone number: (801) 566-1200
ITEM 8.01 OTHER EVENTS
On August 22, 2005, Utah Medical Products, Inc. issued a press release announcing that its FDA trial has been postponed. A copy of the press release is attached hereto as Exhibit 99.1
SIGNATURES
Pursuant to the requirements of the Securities Exchanges Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| | UTAH MEDICAL PRODUCTS, INC. |
| | REGISTRANT |
| | | |
| | | |
Date: 8/22/05 | By: | /s/ Kevin L. Cornwell |
| | | Kevin L. Cornwell |
| | | CEO |
EXHIBIT INDEX
| Index | |
Number | Description |
| | |
| 99.1 | Press release issued August 22, 2005: FDA Trial Postponed |
